The Mutant Mouse Resource and Research Center at The Jackson Laboratory

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

↗ Live URL (may be dead)

Document text

Principal Investigator: Cathleen M Lutz
Organization: JACKSON LABORATORY
Fiscal Year: 2021
Award: $491,863
Funding agency: NIH Office of the Director

Abstract
To date, most of the research using mouse models for COVID-19 has been done using a transgenic
mouse model expressing high levels of the human ACE2gene driven by the Keratin-18(K18) promoter.
While this model has been extremely useful, it has some notable limitations: disease progression is
rapid and invariably fatal within one week, with an uncharacteristically high infection rate in the brain.
These features restrict its use to study the biology related to the acute phase of the infection, leaving a
gap in models that more accurately reflect the expression patterns and levels of the ACE2 receptor, and
that extend the disease course beyond the acute phase of infection.
We will employ a refined genetic strategy utilizing a recently published knock-in model of the human
ACE2 cDNA into the mouse Ace2 locus. By crossing these hACE2 knock-in mice with inbred
Collaborative Cross (CC) founder strains, and by characterizing the response of resulting humanized
F1 progeny to live SARS-CoV-2 infection through an established partnership with researchers at the
Trudeau Institute, we will test the hypothesis that clinical variation in COVID-19 patient response can
be more accurately modelled and phenotypically characterized in mice with naturally regulated ACE2
expression on variable genetic backgrounds.
Consistent with the aims of MMRRC parent grant to identify and distribute mouse models to the
biomedical community, this proposal aims to rapidly provide the research community with an urgently
needed resource for linking the variability in COVID-19 disease outcome with underlying host genetic
features, and for developing precision models for post infection sequelae.

Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ACE2><Acute><Animal Model><Animal Models and Related Studies><Animals><Basic Research><Basic Science><Biology><Biomedical Research><Body Tissues><Body Weight decreased><Brain><Brain Nervous System><Breeding><COVID infected patient><COVID patient><COVID positive patient><COVID-19><COVID-19 infected patient><COVID-19 infection><COVID-19 patient><COVID-19 positive patient><COVID-19 virus><COVID19><COVID19 infection><COVID19 patient><COVID19 positive patient><COVID19 virus><CV-19><CV19><Catalogs><Clinical><CoV-2><CoV2><Communities><Complementary DNA><Complex><DNA Alteration><DNA Sequence Alteration><DNA mutation><DNA seq><DNA sequencing><DNAseq><Data><Development and Research><Disease><Disease Outcome><Disease Progression><Disorder><Dose><Encephalon><Engineering><Ensure><Feedback><Future><Gene Transcription><Gene variant><Genes><Genetic><Genetic Engineering><Genetic Engineering Biotechnology><Genetic Engineering Molecular Biology><Genetic Transcription><Genetic mutation><Genome><Heterogeneity><Histologic><Histologically><Human><Inbred Strain><Inbreeding><Infection><Institutes><Investigators><KI mice><Keratin><Knock-in><Knock-in Mouse><Laboratory mice><Leadership><Light><Link><Measures><Mice><Mice Mammals><Modeling><Modern Man><Monitor><Murine><Mus><Mutant Strains Mice><Outcome><Pattern><Phase><Phenotype><Photoradiation><Physiology><Predisposition><Process><Publishing><R & D><R&D><RNA Expression><RNA Seq><RNA sequencing><RNAseq><Receptor Protein><Recombinant DNA Technology><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Role><SARS corona virus 2><SARS-CoV-2><SARS-CoV-2 infected patient><SARS-CoV-2 infection><SARS-CoV-2 patient><SARS-CoV-2 positive patient><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Scientist><Sequence Alteration><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome related corona virus 2><Ships><Specificity><Speed><Susceptibility><Technology><Testing><The Jackson Laboratory><Tissue Sample><Tissues><Transcription><Transgenic Mice><Variant><Variation><Viral><Weight Loss><Weight Reduction><Wuhan coronavirus><allele variant><allelic variant><angiotensin converting enzyme 2><angiotensin converting enzyme II><base><biobank><biorepository><body weight loss><cDNA><catalog><cohort><corona virus disease 2019><coronavirus disease 2019><coronavirus disease 2019 infected patient><coronavirus disease 2019 infection><coronavirus disease 2019 patient><coronavirus disease 2019 positive patient><coronavirus disease 2019 virus><coronavirus disease infected patient><coronavirus disease patient><coronavirus disease positive patient><coronavirus patient><drug detection><drug testing><experience><genetic approach><genetic strategy><genetic variant><genetically engineered><genomic alteration><genomic variant><global gene expression><global transcription profile><hCoV19><human model><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><infection rate><knockin><knockin mice><model development><model of animal><model of human><model organism><mouse genetics><mouse model><mouse mutant><murine model><nCoV2><parent grant><patient infected with COVID><patient infected with COVID-19><patient infected with SARS-CoV-2><patient infected with coronavirus disease><patient infected with coronavirus disease 2019><patient infected with severe acute respiratory syndrome coronavirus 2><patient response><patient specific response><patient with COVID><patient with COVID-19><patient with COVID19><patient with SARS-CoV-2><patient with coronavirus disease><patient with coronavirus disease 2019><patient with severe acute respiratory distress syndrome coronavirus 2><pre-clinical><preclinical><promoter><promotor><rate of infection><receptor><research and development><response><responsive patient><severe acute respiratory syndrome coronavirus 2 infected patient><severe acute respiratory syndrome coronavirus 2 patient><severe acute respiratory syndrome coronavirus 2 positive patient><social role><tool><transcriptome><transcriptome sequencing><transcriptomics><viral genomics><virus genomics><wt-loss>